课题基金 / 基金详情

ACYCLOVIR CREAM FOR THE TREATMENT OF HERPES LABIALIS LESIONS

ACYCLOVIR CREAM FOR THE TREATMENT OF HERPES LABIALIS LESIONS
用于治疗唇疱疹病变的阿昔洛韦乳膏
批准号：
6218069
负责人：
MARK J KUTCHER
金额：
$0.02万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6218069
关键词：
Herpes simplex disease acyclovir clinical research drug screening /evaluation human subject human therapy evaluation microorganism disease chemotherapy topical drug application

项目摘要

项目成果

MARK J KUTCHER的其他基金

相似基金

相关文献

中文摘要
翻译
一项多中心、随机、双盲、安慰剂对照研究，旨在评价外用阿昔洛韦（5%）乳膏与安慰剂乳膏相比，在下一次唇疱疹发作开始后开始治疗的免疫功能正常受试者中治疗唇疱疹病变的疗效和安全性。 将检查典型病变的愈合时间（从水疱形成至硬壳消失的时间）和病变“流产”（即，发作未进展至丘疹期[无水疱形成]）作为次要变量。其他次要指标包括疼痛、压痛、病毒脱落。
英文摘要
Multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy & safety of topical acyclovir (5%) cream vs. placebo cream in treatment of herpes labialis lesions in immunocompetent subjects initiating treatment after the beginning of the next herpes labialis episode. Time to healing for classical lesions (time from vesicle formation until loss of hard crust) and lesion "abortion" (ie, episode does not progress beyond papular stage [no vesicle form]) will be examined as secondary variable. Other secondary measures will include pain, tenderness, viral shedding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PATIENT APPLIED 2 OCTYL CYANOACRYLATE ORAL TISSUE ADHESIVE
2 OCTYL CYANOACRYLATE TISSUE ADHESIVE FOR ORAL APHTHOUS ULCER
ACYCLOVIR CREAM FOR THE TREATMENT OF HERPES LABIALIS LESIONS
ACYCLOVIR CREAM FOR THE TREATMENT OF HERPES LABIALIS LESIONS
海外基金